No black box warning on record for Tigecycline

As of the latest FDA labeling reviewed, Tigecycline (TIGECYCLINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tigecycline medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0.6% (95% CI 0.1, 1.2). The cause of this increase has not been established. An increase was also seen in a meta-analysis limited to the approved indications [0.6% (95% CI 0, 1

No black box warning on record for Tigecycline

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0.6% (95% CI 0.1, 1.2). The cause of this increase has not been established. An increase was also seen in a meta-analysis limited to the approved indications [0.6% (95% CI 0, 1

Tigecycline Black Box Warning

No black box warning on record for Tigecycline

Other warnings & precautions

Tigecycline Black Box Warning

No black box warning on record for Tigecycline

Other warnings & precautions